Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Naoya Kawashima"'
Autor:
Naoya Kawashima, Kan Akatsu
Publikováno v:
2020 23rd International Conference on Electrical Machines and Systems (ICEMS).
This paper describes a novel estimation method of an instantaneous output torque and also describes a direct torque control method using the torque estimation method. The proposed method can estimate the torque in each stator tooth by using measured
Autor:
Naoya Kawashima, Tomohiro Omura, Michihito Onishi, Marija Renic, Raymond C. Koehler, Judith A. Klaus, Richard J. Roman, David R. Harder, Noriyuki Miyata
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 29:629-639
This study examined the effects of an inhibitor of 20-hydroxyeicosatetraenoic acid (20-HETE) synthesis, N-(3-chloro-4-morpholin-4-yl)phenyl- N'-hydroxyimido formamide (TS-011), on infarct volume, volume at risk, cerebral blood flow (CBF), and levels
Publikováno v:
CNS Drug Reviews. 9:375-388
Schizophrenia is a serious and disabling psychiatric disorder affecting approximately 1% of the world's population. Anew generation of atypical antipsychotics has been introduced over the past decade. These atypical antipsychotics have comparable or
Publikováno v:
Brain Research. 1042:92-98
(1R,2R,3R,5R,6R)-2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039), a selective group II metabotropic glutamate receptor (mGluR) antagonist, exhibits antidepressant-like activities in rodent models. In the
Publikováno v:
Pharmacology Biochemistry and Behavior. 69:445-449
Effects of corticotropin-releasing factor (CRF) subtype 1 receptor antagonists on learned helplessness (LH) were examined in rats. Repeated administration of CRF(1) receptor antagonists, CRA1000 (3 mg/kg, po) and CP-154,526 (10 mg/kg, po), and tricyc
Autor:
Takashi Sakagawa, Toshihiro Ichiki, Osamu Nakagawasai, Takeshi Tadano, Shigeru Okuyama, Naoya Kawashima, Kensuke Kisara, Tadashi Inagami, Soichi Hozumi
Publikováno v:
Life Sciences. 67:2577-2585
The main biological role of angiotensin II type 2 receptor (AT 2 ) has not been established. We made use of targeted disruption of the mouse AT 2 gene to examine the functional role of the AT 2 receptor in the central nervous system (CNS). We have pr
Publikováno v:
Life Sciences. 65:2561-2571
Extracellular single-unit activities of dopamine neurons were recorded using chloral hydrate anaesthetized rats. We examined the reversal effects of the selective dopamine D 4 receptor blockers, NRA0160 (2-Carbamoyl-4-(4-fluorophenyl)-5-[2-[4-(3-fluo
Publikováno v:
General Pharmacology: The Vascular System. 32:637-646
Pharmacological characteristics of NRA compounds, novel atypical antipsychotics, were compared with those of clozapine and haloperidol, in regard to modification of Fos-like immunoreactivity (FLI) in rats. ( R )-(+)-2-Amino-4-(4-fluorophenyl)-5-[1-[4
Autor:
Keiko Yamada, Seiji Hori, Masanobu Kano, Shin-ichi Ogawa, Kei Watase, Kouichi Hashimoto, Yoshiro Inoue, Misato Takimoto, Takashi Sakagawa, Kohichi Tanaka, Keiji Wada, Shigeru Okuyama, Masahiko Watanabe, Naoya Kawashima
Publikováno v:
European Journal of Neuroscience. 10:976-988
To study the function of GLAST, a glutamate transporter highly expressed in the cerebellar Bergmann astrocytes, the mouse GLAST gene was inactivated. GLAST-deficient mice developed normally and could manage simple coordinated tasks, such as staying o
Autor:
Kazuyuki Tomisawa, Kazumasa Yamaguchi, Shigeru Okuyama, Shin-ichi Ogawa, Atsuro Nakazato, Toshihito Kumagai, Masashi Nagamine, Naoya Kawashima, Yoshiko Suzuki, Shigeyuki Chaki
Publikováno v:
British Journal of Pharmacology. 121:515-525
1. The atypical antipsychotic profile of (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl] thiazole (NRA0045), a potent dopamine D4 and 5-hydroxytryptamine (5-HT)2A receptor antagonist, was examined in rats. 2.